Skip to main content

Advertisement

SpringerLink
Log in

A mathematical study on the effects of a combination of an immune checkpoint inhibitor and a mutagen for anti-HIV-1 therapy

  • Original Article
  • Published:
Artificial Life and Robotics Aims and scope Submit manuscript

Abstract

This study mathematically and computationally analyzes the effects of a combination of a chemical mutagen and an immune checkpoint inhibitor to develop an alternative anti-retroviral therapy. First, we addressed how the condition for HIV cure depends the efficacy of these two agents. We concluded that HIV cure only depends on the efficacy of the chemical mutagen, not on the immune checkpoint inhibitor. In other words, the combinatorial use of the two agents did not affect the necessary condition for the HIV “cured state”. On the other hand, we confirmed the effectiveness of the combinatorial treatment with the two agents on the eradication of productively infected cells. Computer simulations clarified that combination treatment with the two agents enables eradication of productively infected cells faster than does treatment with the mutagen alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig.4

Similar content being viewed by others

References

  1. Loeb LA, Essigmann JM, Kazazi F et al (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci USA 96:1492–1497

    Article  Google Scholar 

  2. Mullins JI, Heath L, Hughes JP et al (2011) Mutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461. PLoS ONE 6(1):e15135. https://doi.org/10.1371/journal.pone.0015135

    Article  Google Scholar 

  3. Harada K (2019) A mathematical study for the development of anti-HIV-1 therapies based on the lethal mutagenesis method. Artif Life Robot. https://doi.org/10.1007/s10015-019-00578-2

    Article  Google Scholar 

  4. Gay CL, Bosch RJ, Ritz J et al (2017) Clinical trial of the anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy. J Infect Dis 215(11):1725–1733. https://doi.org/10.1093/infdis/jix191

    Article  Google Scholar 

  5. Day CL, Kaufmann DE, Kiepiela P et al (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443(7109):350–354

    Article  Google Scholar 

  6. Trautmann L, Janbazian L, Chomont N et al (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 12(10):1198–1202

    Article  Google Scholar 

  7. Chu HH, Chan SW, Gosling JP et al (2016) Continuous effector CD8(+) T cell production in a controlled persistent infection is sustained by a proliferative intermediate population. Immunity 45(1):159–171

    Article  Google Scholar 

  8. Sedaghat AR, Siliciano RF, Wilke CO (2008) Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART. BMC Infect Dis 8:2. https://doi.org/10.1186/1471-2334-8-2

    Article  Google Scholar 

  9. Callaway DS, Perelson AS (2002) HIV-1 infection and low steady state viral loads. Bull Math Biol 64(1):29–64

    Article  Google Scholar 

  10. Guo T, Qiu Z (2019) The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission. Math Biosci Eng 16(6):6822–6841

    Article  MathSciNet  Google Scholar 

  11. Mansky LM, Temin HM (1995) Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69(8):5087–5094

    Article  Google Scholar 

  12. Akhmetzyanova I, Drabczyk M, Neff CP, Gibbert K, Dietze KK, Werner T et al (2015) PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing. PLoS Pathog 11(10):e1005224. https://doi.org/10.1371/journal.ppat.1005224

    Article  Google Scholar 

  13. Lotka AJ (1910) Contribution to the Theory of Periodic Reaction. J Phys Chem 14(3):271–274. https://doi.org/10.1021/j150111a004

    Article  Google Scholar 

  14. Finzi D, Hermankova M, Pierson T et al (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278(5341):1295–1300

    Article  Google Scholar 

  15. Finzi D, Blankson J, Siliciano JD et al (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5(5):512–517. https://doi.org/10.1038/8394

    Article  Google Scholar 

  16. Hosmane NN, Kwon KJ, Bruner KM et al (2017) Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics. J Exp Med 214(4):959–972. https://doi.org/10.1084/jem.20170193

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Computer Science and Engineering, Toyohashi University of Technology, Toyohashi, Japan

    Kouji Harada

  2. Research Institute for Interdisciplinary Science, Okayama University, Okayama, Japan

    Tomonari Sumi

  3. Department of Chemistry, Faculty of Science, Okayama University, Okayama, Japan

    Tomonari Sumi

Authors
  1. Kouji Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomonari Sumi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kouji Harada.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This work was presented in part at the 25th International Symposium on Artificial Life and Robotics (Beppu, Oita, January 22-24, 2020).

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harada, K., Sumi, T. A mathematical study on the effects of a combination of an immune checkpoint inhibitor and a mutagen for anti-HIV-1 therapy. Artif Life Robotics 26, 210–215 (2021). https://doi.org/10.1007/s10015-020-00664-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10015-020-00664-w

Keywords

Search

Navigation